비스포스포네이트 관련 악골괴사에 대한 후향적 연구
Retrospective study on the bisphosphonate-related osteonecrosis of jaw
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Introduction: The incidence of bisphosphonate-related osteonecrosis of the jaw (BRONJ) has increased gradually in patients who have undergone surgical treatment for osteomyelitis. In this study, a retrospective analysis of BRONJ patients was carried out using the data of osteomyelitis patients treated surgically. Materials and Methods: Osteomyelitis patients, who underwent curettage, sequestrectomy, saucerization or decortications, and partial mandibulectomy at Seoul National University Dental Hospital from 2004 to 2010 were enrolled in this study. The patients were classified and categorized into two groups based on the surgical records and progress notes. One group comprised of patients with osteomyelitis and osteoporosis,and the other group included patients with osteomyelitis only. The epidemiological data of the BRONJ patients was analyzed to identify any trend in the incidence of BRONJ in osteomyelitis patients. Results: Among 200 patients who underwent surgical intervention for osteomyelitis, 64 (32.0%) were identified as having osteoporosis as the underlying disease. In these 64 patients, more than 81.3% had been prescribed bisphosphonates. Females were far more affected by BRONJ than males. The incidence of BRONJ also increased with age. The posterior part of the mandible was affected more frequently by BRONJ. Conclusion: Although the availability of potent antibiotics and increased oral hygiene care can reduce the overall incidence of osteomyelitis, BRONJ can increase the total incidence. To prevent BRONJ, it is recommended that an oral examination be performed before prescribing bisphosphonates. Moreover, the patients should be educated about the potential risks of dental procedures that might be causal factors for BRONJ. Furthermore, patient swho take bisphosphonates for the treatment of osteoporosis should undergo periodic follow up oral examinations to prevent BRONJ.
Abstract
Introduction: The incidence of bisphosphonate-related osteonecrosis of the jaw (BRONJ) has increased gradually in patients who have undergone surgical treatment for osteomyelitis. In this study, a retrospective analysis of BRONJ patients was carried out using the data of osteomyelitis patients treated surgically. Materials and Methods: Osteomyelitis patients, who underwent curettage, sequestrectomy, saucerization or decortications, and partial mandibulectomy at Seoul National University Dental Hospital from 2004 to 2010 were enrolled in this study. The patients were classified and categorized into two groups based on the surgical records and progress notes. One group comprised of patients with osteomyelitis and osteoporosis,and the other group included patients with osteomyelitis only. The epidemiological data of the BRONJ patients was analyzed to identify any trend in the incidence of BRONJ in osteomyelitis patients. Results: Among 200 patients who underwent surgical intervention for osteomyelitis, 64 (32.0%) were identified as having osteoporosis as the underlying disease. In these 64 patients, more than 81.3% had been prescribed bisphosphonates. Females were far more affected by BRONJ than males. The incidence of BRONJ also increased with age. The posterior part of the mandible was affected more frequently by BRONJ. Conclusion: Although the availability of potent antibiotics and increased oral hygiene care can reduce the overall incidence of osteomyelitis, BRONJ can increase the total incidence. To prevent BRONJ, it is recommended that an oral examination be performed before prescribing bisphosphonates. Moreover, the patients should be educated about the potential risks of dental procedures that might be causal factors for BRONJ. Furthermore, patient swho take bisphosphonates for the treatment of osteoporosis should undergo periodic follow up oral examinations to prevent BRONJ.
참고문헌 (20)
- Marx RE, "Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic", J Oral Maxillofac Surg, 61, pp.1115~1117 (2003)
- Rogers MJ, "New insights into the molecular mechanisms of action of bisphosphonates", Curr Pharm Des, 9, pp.2643~2658 (2003)
- Otto S, "Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study", J Craniomaxillofac Surg, 39, pp.272~277 (2011)
- 대한내분비학회, "비스포스포네이트와 관련한 악골(턱뼈) 괴사", 대한내분비학회지, 24(4), pp.227~230 (2009), 대한내분비학회
- Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons, "American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 65, pp.369~376 (2007)
- Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update", J Oral Maxillofac Surg, 67(5 Suppl), pp.2~12 (2009)
- Ruggiero SL, "Osteonecrosis of the jaws and bisphosphonate therapy", J Dent Res, 86, pp.1013~1021 (2007)
- Saussez S, "Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: a Belgian case series", Laryngoscope, 119, pp.323~329 (2009)
- Hoefert S, "Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw", J Oral Maxillofac Surg, pp.362~380 (2011)
- Khosla S, "American Society for Bone and Mineral Research. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research", J Bone Miner Res, 22, pp.1479~1491 (2007)
- Migliorati CA, "Bisphosphonate- associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy", Cancer, 104, pp.83~93 (2005)
- Rizzoli R, "Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis", Bone, 42, pp.841~847 (2008)
- Adamo V, "Current knowledge and future directions on bisphosphonaterelated osteonecrosis of the jaw in cancer patients", Expert Opin Pharmacother, 9, pp.1351~1361 (2008)
- Sarin J, "Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis", Oral Dis, 14, pp.277~285 (2008)
- Marx RE, "Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment", J Oral Maxillofac Surg, 65, pp.2397~2410 (2007)
- Allen MR, "Higher bone matrix density exists in only a subset of patients with bisphosphonate-related osteonecrosis of the jaw", J Oral Maxillofac Surg, 67, pp.1373~1377 (2009)
- Magopoulos C, "Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals", Am J Otolaryngol, 28, pp.158~163 (2007)
- Vescovi P, "Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 66, pp.831~832 (2008)
- Carlson ER, "The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 67(5 Suppl), pp.85~95 (2009)
- Shimura K, "Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate-induced osteonecrosis of the jaw in a patient with multiple myeloma", Int J Hematol, 84, pp.343~345 (2006)